Search Within
Document Type
249-260-9
Applied Filters:
Keyword:'249-260-9'
Showing 1-30 of 40 results for "249-260-9" within Technical Documents
Data Sheet - T5536 - Lot 104K8802
Abundance
41 55
79 91
124
134
150
168 187
206
231
249
276
291
40 60 80 100 120 140 160 180 200 220 240 260 280
0
5000
10000
15000
Product Information Sheet-eagletmmro
Cat. No. 07 249 926 190 10 x 5 ml
5,000 reactions of 20 μl final volume each
2x conc.
Cat. No. 07 260 288 190 1 ml
100 reactions of 20 μl final volume each
2x conc.
Data Sheet - N3398
. Shaffer, J.E. et al., J. Pharmacol. Exp. Ther. 260,
286, (1992).
8. Bauer, J.A. and Fung, H.-L., J. Pharmacol Exper.
Ther. 256, 249, (1991).
9. Garg, U.C. and Hassid, A., J. Clin. Invest. 83
Data Sheet - C7420
Woodward, S.R., Hillyard, D.R., Cruz, L.J. "Diversity of conus neuropeptides." Science 249, 257-
263 (1990).
Rev. 9/96
ProductInformation
Acrylamido Buffers
- - 818 -
3-9 1748 - 81 36 214 - 194 1273 -
Product Information Sheet - G6878
D., Experimental depletion of creatine
and phosphocreatine from skeletal muscle. J. Biol.
Chem., 249(4), 1060-1063 (1974).
6. Watanabe, Y., et al., Synthesis of neuroactive
guanidino compounds by
Product Information Sheet - L5385
13. Köhler, C., et al., Protease activation in apoptosis
induced by MAL. Exp. Cell. Res., 249(2), 260-268
(1999).
14. Kit, I., et al., Preparations of human α-lactalbumin,
inducing apoptosis
Product Information Sheet - L6010
13. Köhler, C., et al., Protease activation in apoptosis
induced by MAL. Exp. Cell. Res., 249(2), 260-268
(1999).
14. Kit, I., et al., Preparations of human α-lactalbumin,
inducing apoptosis
XP725 Antibody Number-Lot Number 071M4826
203 204 225 226 227 228 249 250 251 252 273 274 275 276
3.4 205 206 207 208 229 230 231 232 253 254 255 256 277 278 279 280
3.5 209 210 211 212 233 234 235 236 257 258
Product Information Sheet - D1641
C29H37NO5 479.61 218-221
+86.7°
(c = 0.9, MeOH,
21 °C)
Ethanol,
DMSO
C 30382 22144-76-9 C29H37NO6 507.62 260
+14.7°
(c = 0.8, dioxane,
28 °C)
Dichloro-
Methane
D C8273 22144-77-0 C30H37NO6
Product Information Sheet - C6637
C29H37NO5 479.61 218-221
+86.7°
(c = 0.9, MeOH,
21 °C)
Ethanol,
DMSO
C 30382 22144-76-9 C29H37NO6 507.62 260
+14.7°
(c = 0.8, dioxane,
28 °C)
Dichloro-
Methane
D C8273 22144-77-0 C30H37NO6
Product Information Sheet - C2149
C29H37NO5 479.61 218-221
+86.7°
(c = 0.9, MeOH,
21 °C)
Ethanol,
DMSO
C 30382 22144-76-9 C29H37NO6 507.62 260
+14.7°
(c = 0.8, dioxane,
28 °C)
Dichloro-
Methane
D C8273 22144-77-0 C30H37NO6
Product Information Sheet - 30382
C29H37NO5 479.61 218-221
+86.7°
(c = 0.9, MeOH,
21 °C)
Ethanol,
DMSO
C 30382 22144-76-9 C29H37NO6 507.62 260
+14.7°
(c = 0.8, dioxane,
28 °C)
Dichloro-
Methane
D C8273 22144-77-0 C30H37NO6
Product Information Sheet - C6762
C29H37NO5 479.61 218-221
+86.7°
(c = 0.9, MeOH,
21 °C)
Ethanol,
DMSO
C 30382 22144-76-9 C29H37NO6 507.62 260
+14.7°
(c = 0.8, dioxane,
28 °C)
Dichloro-
Methane
D C8273 22144-77-0 C30H37NO6
Product Information Sheet - C8273
C29H37NO5 479.61 218-221
+86.7°
(c = 0.9, MeOH,
21 °C)
Ethanol,
DMSO
C 30382 22144-76-9 C29H37NO6 507.62 260
+14.7°
(c = 0.8, dioxane,
28 °C)
Dichloro-
Methane
D C8273 22144-77-0 C30H37NO6
Product Information Sheet - C0889
C29H37NO5 479.61 218-221
+86.7°
(c = 0.9, MeOH,
21 °C)
Ethanol,
DMSO
C 30382 22144-76-9 C29H37NO6 507.62 260
+14.7°
(c = 0.8, dioxane,
28 °C)
Dichloro-
Methane
D C8273 22144-77-0 C30H37NO6
Product Information Sheet - C0138
Rotation
C6637 14110-64-6 White powder C29H37NO5 477.61 193-195°C
C0138 22144-76-9 White powder C30H37NO6 507.63 260°C
C6762 14930-96-2 White powder C29H37NO5 479.62 218-221°C +86.7 (039% solution w/v
Product Information Sheet - C1139
Rotation
C6637 14110-64-6 White powder C29H37NO5 477.61 193-195°C
C0138 22144-76-9 White powder C30H37NO6 507.63 260°C
C6762 14930-96-2 White powder C29H37NO5 479.62 218-221°C +86.7 (039% solution w/v
TB095 pET-30a-c(+) Vector Map
4595
Enzyme # Sites Locations
NspI 4 651 2622 2914 3281
NspV 1 268
Pfl1108I 1 2063
PflMI 3 260 758 4742
PleI 9 433 725 812 1608 3171
3656 4711 5115 5123
PshAI 1 2021
Psp5II 1 2283
Psp1406I 4 838 2206
TB076VM pET-29a-c(+) Vector Map
4544
NspI 4 600 2571 2863 3230
NspV 1 268
Enzyme # Sites Locations
Pfl1108I 1 2012
PflMI 3 260 707 4691
PleI 9 382 674 761 1557 3120
3605 4660 5064 5072
PshAI 1 1970
Psp5II 1 2232
Psp1406I 4 787 2155
TB122VM pET-32a-c(+) Vector Map
transcription start 763
Trx•Tag coding sequence 366-692
His•Tag coding sequence 327-344
S•Tag coding sequence 249-293
Multiple cloning sites
(Nco I - Xho I) 158-217
His•Tag coding sequence 140-157
T7 terminator 26
Data Sheet-SCC490
development in vitro with
OP9-DL4-7FS cells expressing human cytokines. Methods Mol Biol. 2580:249–260.
5
Academic Use Agreement
Subject to local law
THIS
Product Information Sheet - PP0500
Levy, M. et al., Meth. Enzymol., 19, 672-681
(1970).
20. Taylor, J.M. et al., J. Biol. Chem., 249, 2188-94
(1974).
21. Chartier, F. et al., J. Biol. Chem., 264, 17006-15
(1989).
22. Bousfield
Apoptosis - Antibodies, Reagents and Kits
mouse 5 mini-blots 64-201SP $95
Visualizer Western Blot Detection Kit, mouse 20 mini-blots 64-201 $249
Visualizer Western Blot Detection Kit, mouse 50 mini-blots 64-201BP $359
Visualizer Western Blot
Chromolith HPLC Columns
Prep Si 100-25 mm
Solvent n-Heptane / Dioxane (80/20 v/v)
Flow rate 140 mL/min
Injection 249 mg
Cycle time 25 sec
Sample Fluoro-dihydro-oxyranyl-benzopyran
25 sec
Although
XP725 Antibody List Lot 129K4830
LDS1 L4793 23028 AOF2 P NP_001009999.1 y n/d n/d
41 ASC-2 A5355 23054 NCOA6 M NP_054790.2 y n/d n/d
249 ELKS E4531 23085 ERC1 M NP_829883.1 y y y
569 PhosphatidylSerine Receptor (PSR) P1495 23210 JMJD6 P
XP725 Antibody List Lot 129K4831
LDS1 L4793 23028 AOF2 P NP_001009999.1 y n/d n/d
41 ASC-2 A5355 23054 NCOA6 M NP_054790.2 y n/d n/d
249 ELKS E4531 23085 ERC1 M NP_829883.1 y y y
569 PhosphatidylSerine Receptor (PSR) P1495 23210 JMJD6 P
XP725 Antibody List Lot 089K4791
LDS1 L4793 23028 AOF2 P NP_001009999.1 y n/d n/d
41 ASC-2 A5355 23054 NCOA6 M NP_054790.2 y n/d n/d
249 ELKS E4531 23085 ERC1 M NP_829883.1 y y y
569 PhosphatidylSerine Receptor (PSR) P1495 23210 JMJD6 P
Bioreactor Systems for Bone Tissue Engineering
Webb, K. Tissue engineering therapies for
the vocal fold lamina propria. Tissue Eng Part B Rev 15,
249, 2009.
11. Fiegel, H.C., et al. Hepatic tissue engineering: from trans-
plantation to customized
Chrombook 2015 - The world of chromatography in your hands
%), 240 (85 %),
260 (98 %)1.11727.2500 2.5 L GL
1.11727.4000 4 L GL
1.11727.9030 10 L ST
1.11727.9185 185 L ST
Ethyl acetate 1.00868.1000 1 L GL 99.8 2 0.05 0.0002 0.0002 260 (50 %), 265 (80 %)
Page 1 of 2